US Patent 10016423 Solid forms of nilotinib hydrochloride
Patent 10016423 was granted and assigned to Apotex on July, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10016423 Solid forms of nilotinib hydrochloride
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.